First Manhattan
FLGT icon

First Manhattan’s Fulgent Genetics FLGT Stock Holding History

First Manhattan’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-250
Closed -$5.42K – 883
2024
Q1 		$5.42K Hold
250
– – ﹤0.01% 1186
2023
Q4 		$7.23K Buy
+250
New +$6.69K ﹤0.01% 1158
2022
Q1 		– Sell
-225
Closed -$22K – 1622
2021
Q4 		$22K Hold
225
– – ﹤0.01% 1148
2021
Q3 		$20K Hold
225
– – ﹤0.01% 1169
2021
Q2 		$20K Hold
225
– – ﹤0.01% 1157
2021
Q1 		$21K Buy
+225
New +$23.2K ﹤0.01% 1125

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

First Manhattan's FLGT Position: Q2 2024 in Review

First Manhattan sold out of Fulgent Genetics (FLGT) in Q2 2024, closing a stake of 250 shares — an estimated $5.42K sold.

First Manhattan first reported a position in FLGT in Q1 2021 and held it in 6 quarters. The position peaked at $22K in Q4 2021. 173 funds tracked by Wall St. Rank hold FLGT as of Q2 2024.

  • First Manhattan reported no remaining Fulgent Genetics position as of Q2 2024 after selling out during the quarter.
  • First Manhattan sold 250 Fulgent Genetics shares in Q2 2024, an estimated $5.42K.
  • First Manhattan first reported a position in Fulgent Genetics in Q1 2021 and held it in 6 quarters.
  • First Manhattan's Fulgent Genetics position peaked at $22K in Q4 2021.
  • 173 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2024.

Based on First Manhattan's 13F filing for Q2 2024, filed 14 Aug 2024.